Jpmorgan Chase & CO Tenaya Therapeutics, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.23 Trillion
  • Q4 2024

A detailed history of Jpmorgan Chase & CO transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 5,155,596 shares of TNYA stock, worth $4.64 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,155,596
Previous 24,822 20670.27%
Holding current value
$4.64 Million
Previous $47,000 15585.11%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
BUY
$1.23 - $3.78 $6.31 Million - $19.4 Million
5,130,774 Added 20670.27%
5,155,596 $7.37 Million
Q3 2024

Dec 26, 2024
BUY
$1.93 - $3.99 $1,275 - $2,637
661 Added 2.74%
24,822 $47,000
Q3 2024

Nov 08, 2024
BUY
$1.93 - $3.99 $1,275 - $2,637
661 Added 2.74%
24,822 $47,000
Q2 2024

Dec 26, 2024
SELL
$2.72 - $4.99 $1,797 - $3,298
-661 Reduced 2.66%
24,161 $74,000
Q2 2024

Aug 12, 2024
BUY
$2.72 - $4.99 $14,231 - $26,107
5,232 Added 27.64%
24,161 $74,000
Q1 2024

Dec 26, 2024
SELL
$2.88 - $6.8 $16,971 - $40,072
-5,893 Reduced 23.74%
18,929 $98,000
Q1 2024

May 10, 2024
SELL
$2.88 - $6.8 $31,469 - $74,303
-10,927 Reduced 36.6%
18,929 $98,000
Q4 2023

Dec 26, 2024
BUY
$1.73 - $3.39 $8,708 - $17,065
5,034 Added 20.28%
29,856 $96,000
Q4 2023

Feb 12, 2024
SELL
$1.73 - $3.39 $13 - $27
-8 Reduced 0.03%
29,856 $96,000
Q3 2023

Nov 14, 2023
SELL
$2.55 - $5.65 $14,843 - $32,888
-5,821 Reduced 16.31%
29,864 $76,000
Q2 2023

Aug 11, 2023
BUY
$2.64 - $7.64 $2,684 - $7,769
1,017 Added 2.93%
35,685 $209,000
Q1 2023

May 18, 2023
BUY
$1.92 - $3.59 $63,684 - $119,076
33,169 Added 2212.74%
34,668 $98,000
Q1 2023

May 11, 2023
SELL
$1.92 - $3.59 $30,370 - $56,786
-15,818 Reduced 91.34%
1,499 $4,000
Q4 2022

Feb 13, 2023
BUY
$1.68 - $3.19 $35 - $66
21 Added 0.12%
17,317 $35,000
Q3 2022

Nov 14, 2022
BUY
$2.9 - $5.88 $1,789 - $3,627
617 Added 3.7%
17,296 $50,000
Q2 2022

Aug 11, 2022
SELL
$5.01 - $14.12 $26,036 - $73,381
-5,197 Reduced 23.76%
16,679 $94,000
Q1 2022

May 11, 2022
BUY
$9.41 - $19.3 $90,778 - $186,187
9,647 Added 78.89%
21,876 $258,000
Q4 2021

Feb 10, 2022
BUY
$18.41 - $29.58 $101,310 - $162,778
5,503 Added 81.82%
12,229 $232,000
Q3 2021

Nov 12, 2021
BUY
$15.35 - $26.66 $103,244 - $179,315
6,726 New
6,726 $139,000

Others Institutions Holding TNYA

# of Institutions
100
Shares Held
56.7M
Call Options Held
900
Put Options Held
400
View Full List

About Tenaya Therapeutics, Inc.

TNYA Quotes by TradingView
  • Ticker TNYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,364,700
  • Market Cap $37.2M
  • Description
  • Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...
More about TNYA
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email